Sponsor Pipeline

Regina Elena Cancer Institute Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
38
Active Trials
32
Recruiting
2
Phase 3
10
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT06717711
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After…
date change Primary completion pushed: 2025-08-31 -> 2027-02-28
2026-08-15 NCT06717711
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After…
date change Completion pushed: 2026-08-31 -> 2028-02-28
Active Trials by Phase
Phase 3
2
Phase 2
4
Not specified
32
Active Trials — top 25 of 38
NCT IDTitleConditionStatus
Phase 3
NCT06717711 Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After… Prostate Carcinoma Recruiting
NCT05776758 Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt Muscle-Invasive Bladder Carcinoma Active, Not Recruiting
Phase 2
NCT05557604 Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer Prostate Cancer Recruiting
NCT06771518 Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment… Small Cell Lung Cancer Recruiting
NCT06224244 External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast… Breast Neoplasms Active, Not Recruiting
NCT06880289 Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and… Squamous Cell Tumors of the Head and Neck Active, Not Recruiting
Not specified
NCT05918510 Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult… Squamous Cell Carcinoma of the Oropharynx Recruiting
NCT06442020 Low Intensity Shock Wave Therapy in the Rehabilitation Treatment of Erectile Dysfunction… Erectile Dysfunction Recruiting
NCT06519500 Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract… Gastro-entero-pancreatic Neoplasms Recruiting
NCT06272799 Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer… Breast Cancer Recruiting
NCT05940311 Versatile Ampification Single-Molecule Detection in Liquid Biopsy Liquid Biopsy Recruiting
NCT05789667 Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated… Differentiated Thyroid Cancer Recruiting
NCT06736015 Myo-inositol and Selenium in Indeterminate Thyroid Nodules (TIR3a) Thyroid Nodule Recruiting
NCT06786663 MALE Mamm Organoids Breast Neoplasms, Male Recruiting
NCT06787625 Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases Colo-rectal Cancer Recruiting
NCT06791941 Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent… Head and Neck Tumors Recruiting
NCT06807307 Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in… NSCLC Recruiting
NCT06841653 A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management… Endometrium Cancer Recruiting
NCT06875414 Breast Cancer and Resilience in Couple Breast Neoplasms Recruiting
NCT06878027 Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool Bladder Cancer Recruiting
NCT06883201 Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer Breast Cancer Recruiting
NCT06894628 Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme'… Prostatic Neoplasms Recruiting
NCT06992973 Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With… Brain Metastases Recruiting
NCT06992986 Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy… Bladder Cancer Recruiting
NCT07248878 Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing… Cervical Cancer Stage IB2 Recruiting
See all 38 active Regina Elena Cancer Institute trials with filters →
Disease Areas
Get alerts when Regina Elena Cancer Institute's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free